Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 29;18(1):198.
doi: 10.3390/ijerph18010198.

Gender Differences and Quality of Life in Parkinson's Disease

Affiliations
Review

Gender Differences and Quality of Life in Parkinson's Disease

Pietro Crispino et al. Int J Environ Res Public Health. .

Abstract

Parkinson's disease has been found to significantly affect health-related quality of life. The gender differences of the health-related quality of life of subjects with Parkinson's disease have been observed in a number of studies. These differences have been reported in terms of the age at onset, clinical manifestations, and response to therapy. In general, women with Parkinson's disease showed more positive disease outcomes with regard to emotion processing, non-motor symptoms, and cognitive functions, although women report more Parkinson's disease-related clinical manifestations. Female gender predicted poor physical functioning and socioemotional health-related quality of life, while male gender predicted the cognitive domain of health-related quality of life. Some studies reported gender differences in the association between health-related quality of life and non-motor symptoms. Depression and fatigue were the main causes of poorer health-related quality of life in women, even in the early stages of Parkinson's disease. The aim of this review was to collect the best available evidence on gender differences in the development of Parkinson's disease symptoms and health-related quality of life.

Keywords: Parkinson’s disease; dopamine; gender; levodopa; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) Qual. Life Res. 1993;2:153–159. doi: 10.1007/BF00435734. - DOI - PubMed
    1. Sosnowski R., Kulpa M., Ziętalewicz U., Wolski J.K., Nowakowski R., Bakuła R., Demkow T. Basic issues concerning health-related quality of life. Cent. Eur. J. Urol. 2017;70:206–211. doi: 10.5173/ceju.2017.923. - DOI - PMC - PubMed
    1. Vitale S.G., Caruso S., Rapisarda A.M.C., Valenti G., Rossetti D., Cianci S., Cianci A. Biocompatible porcine dermis graft to treat severe cystocele: Impact on quality of life and sexuality. Arch. Gynecol. Obstet. 2016;293:125–131. doi: 10.1007/s00404-015-3820-0. - DOI - PubMed
    1. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003;157:1015–1022. doi: 10.1093/aje/kwg068. - DOI - PubMed
    1. Dluzen D.E., McDermott J.L. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: Implications for Parkinson’s disease. J. Gend. Specif. Med. 2000;3:36–42. - PubMed